Zejula (niraparib) - GSK, ZAI Lab, J&J, Takeda
dostarlimab (TSR-042) - GSK
Zejula + dostarlimab:Data from P2 MOONSTONE trial (NCT03955471) for 2L PROC ovarian cancer in H2 2021 (GSK) - Jul 29, 2020 - Q2 2020 Results 
P2 data • Oncology • Ovarian Cancer
https://www.gsk.com/media/6068/q2-2020-results-slides.pdf
 
Jul 29, 2020
 
 
99a62e9d-4280-4b4b-8dd9-89ec93345d42.png